Eterna Therapeutics
ERNA
$0.28
Share price
-22.93%
Change (1 day)
-91.93%
Change (1 year)
Categories
Eterna Therapeutics (ERNA) Fails to deliver data
Key failure to deliver metrics for Eterna Therapeutics:
- Last SEC data release: 2025-03-14
- Last 15 days FTD volume: A$0 M
- Last 3 months FTD volume: A$1.45 M
- Last year FTD volume: A$1.45 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2022
Volume in USD (price x number of shares), data since 2022Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | A$1.44 M | 89.66% |
| 2024 | A$0.76 M | 88.02% |
| 2023 | A$0.4 M | -70.43% |
| 2022 | A$1.37 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | A$17.33 M | A$48.35 M | 🇺🇸 USA |
 | A$5.14 M | A$26.95 M | 🇺🇸 USA |
 | A$1.78 M | A$6.33 M | 🇺🇸 USA |
 | A$6.86 M | A$53.59 M | 🇫🇷 France |
 | A$0.56 M | A$17.99 M | 🇺🇸 USA |
 | N/A | A$1.12 M | 🇦🇺 Australia |
 | A$7.97 M | A$37.34 M | 🇮🇱 Israel |